Egyptian singer Mohamed Tharwat revealed that his son, the young director Ahmed Tharwath, 36, had a rare immune disease called Miller Fisher Syndrome.

And in an intervention with the Egyptian satellite channel "dmc" (dmc) yesterday evening, Sunday, Tharwat said, "Ahmed is in severe pain, and I feel very sorry for him. His disease is rare, and the percentage of people infected with it does not exceed one in a million. The disease affects the nervous system. Ahmed's condition is unstable. Pray for him to recover."

Two days ago, Ahmed posted a post on his Facebook page, saying, "On a normal day, I suffer from a health problem, and after a week of examinations, I discover that I have a rare immune disease in the nervous system (Miller Fisher syndrome), which attacks the body and prevents you from fully moving."

He added, "God wills to save me at the appropriate time with a medical team at the highest level of professors and nursing staff inside and outside Egypt to control the spread of this syndrome in a timely manner, and God willing, I will continue the journey of recovery during the coming days."

In a press statement, the artist, Mostafa Kamel, the head of the Syndicate of Musical Professions, appealed to "the musical and artistic community and lovers of authentic art to pray for the son of the great artist, Muhammad Tharwat."

Ahmed Tharwat is a musician, poet, rapper and hip-hop singer. He was born in 1987. He studied at the Faculty of Engineering, Department of Electricity, and directed a number of television works.

What is Miller Fisher syndrome?

According to Medical News Today, Miller Fisher Syndrome (MFS) is a rare neurological disease that causes the immune system to attack nerves and causes problems with eye and facial movements, coordination and balance.

The syndrome is a milder type of Guillain-Barre Syndrome (GBS), both of which are autoimmune diseases that develop when the immune system attacks the nervous system.

What is the cause of Miller Fisher syndrome?

It is not medically clear why some people develop this syndrome, but some people have been observed to develop it after vaccination or surgery.

Symptoms of Miller Fisher Syndrome

  • Balance problems and changes in the way you walk.

  • Double or blurred vision and problems with eye movements.

  • Drooping eyelids or difficulty moving facial muscles.

  • Tendons in the ankle, knee, or arm are affected.

  • It can also progress to breathing problems, muscle weakness of the arms and legs, swallowing problems, and slurred speech.

How to treat Miller Fisher syndrome

According to the National Institute of Neurological Disorders and Stroke (NINDS), there are two primary treatment options for the syndrome. The first involves injecting immunoglobulin proteins into the veins. The alternative method is a process called plasma exchange, which is a procedure to cleanse the blood.

Plasma exchange involves removing some of the blood plasma, cleaning it, and then returning it to the body. Plasma exchange can take several hours and is a more difficult procedure than immunoglobulin therapy, so most doctors prefer intravenous treatment with immunoglobulin proteins.

People who develop Miller Fisher syndrome may need to use a ventilator or a heart monitor and will likely need constant monitoring in the hospital.

How long does the recovery period take?

Doctors generally view Miller Fisher patients in a positive light, with most beginning to recover within 2 to 4 weeks, with full recovery taking longer.

Although most people recover well within about 6 months, some people experience lasting effects, and relapses can occur months or years later.